A Comparative Study of [F-18] Florbetaben (FBB) PET Imaging, Pathology, and Cognition between Normal and Alzheimer Transgenic Mice

다국어 초록 (Multilingual Abstract)

Alzheimer's disease (AD) is highly prevalent in dementia, with no specifically effective treatment having yet been discovered. Amyloid plaques are one of the key hallmarks of AD. Transgenic mouse models exhibiting Alzheimer's disease-like pathology have been widely used to study the pathophysiology of Alzheimer's disease. In this study, we showed an age-dependent correlation between cognitive function, pathological findings, and [F-18] Florbetaben (FBB) PET images. Nineteen transgenic mice (12 with AD, 7 with controls) were used for this study. We observed an increase in β-Amyloid deposition (Aβ) in brain tissue and [F-18] FBB amyloid PET imaging in the AD group. The [F-18] FBB data showed a mildly negative trend with cognitive function. Pathological findings were negatively correlated with cognitive functions. These finding suggests that amyloid beta deposition can be well-monitored with [F-18] FBB PET and a decline in cognitive function is related to the increase in amyloid plaque burden.

참고문헌 (Reference)

1 Elder GA, "Transgenic mouse models of alzheimer's disease" 77 : 69-81, 2010

2 Christie R, "Structural and functional disruption of vascular smooth muscle cells in a transgenic mouse model of amyloid angiopathy" 158 : 1065-1071, 2001

3 Manook A, "Small-animal pet imaging of amyloid-beta plaques with [11c] pib and its multimodal validation in an app/ps1 mouse model of alzheimer's disease" 7 : e31310-, 2012

4 King DL, "Progressive and gender-dependent cognitive impairment in the appsw transgenic mouse model for alzheimer's disease" 103 : 145-162, 1999

5 Rowe CC, "Predicting alzheimer disease with β-amyloid imaging: Results from the australian imaging, biomarkers, and lifestyle study of ageing" 74 : 905-913, 2013

6 Tijms BM, "Pre-amyloid stage of alzheimer's disease in cognitively normal individuals" 5 : 1037-1047, 2018

7 Chatziioannou AF, "Pet scanners dedicated to molecular imaging of small animal models" 4 : 47-63, 2002

8 Snellman A, "Longitudinal amyloid imaging in mouse brain with 11c-pib: Comparison of app23, tg2576, and appswe-ps1de9 mouse models of alzheimer disease" 54 : 1434-1441, 2013

9 Kuntner C, "Limitations of small animal pet imaging with [18f]fddnp and fdg for quantitative studies in a transgenic mouse model of alzheimer's disease" 11 : 236-240, 2009

10 Ashe KH, "Learning and memory in transgenic mice modeling alzheimer's disease" 8 : 301-308, 2001

11 Chapman PF, "Impaired synaptic plasticity and learning in aged amyloid precursor protein transgenic mice" 2 : 271-, 1999

12 Fueger BJ, "Impact of animal handling on the results of 18f-fdg pet studies in mice" 47 : 999-, 2006

13 Klunk WE, "Imaging the pathology of alzheimer's disease: Amyloid-imaging with positron emission tomography" 13 : 781-789, 2003

14 Aizenstein HJ, "Frequent amyloid deposition without significant cognitive impairment among the elderly" 65 : 1509-1517, 2008

15 Khachaturian ZS, "Diagnosis of alzheimer's disease" 42 : 1097-1105, 1985

16 Molinuevo JL, "Current state of alzheimer's fluid biomarkers" 1-33, 2018

17 Hsiao K, "Correlative memory deficits, Aβ elevation, and amyloid plaques in transgenic mice" 274 : 99-103, 1996

18 Gordon MN, "Correlation between cognitive deficits and Aβ deposits in transgenic app+ ps1 mice" 22 : 377-385, 2001

19 Klunk WE, "Binding of the positron emission tomography tracer pittsburgh compound-b reflects the amount of amyloid-β in alzheimer's disease brain but not in transgenic mouse brain" 25 : 10598-10606, 2005

20 Morgan D, "Aβ peptide vaccination prevents memory loss in an animal model of alzheimer's disease" 408 : 982-, 2000

21 Villemagne VL, "Aβ deposits in older non-demented individuals with cognitive decline are indicative of preclinical alzheimer's disease" 46 : 1688-1697, 2008

22 Choi GE, "Autophagy deficiency in myeloid cells exacerbates eosinophilic inflammation in chronic rhinosinusitis" 141 : 938-950.e912, 2018

23 Miedel CJ, "Assessment of spontaneous alternation, novel object recognition and limb clasping in transgenic mouse models of amyloid- β and tau neuropathology" 2017

24 Son HJ, "Assessment of brain betaamyloid deposition in transgenic mouse models of alzheimer's disease with pet imaging agents 18 f-flutemetamol and 18 f-florbetaben" 19 : 45-, 2018

25 Drzezga A, "Amyloid-plaque imaging in early and differential diagnosis of dementia" 24 : 55-66, 2010

26 Holtzman DM, "Alzheimer's disease: The challenge of the second century" 3 : 77-71, 2011

27 Moran PM, "Age-related learning deficits in transgenic mice expressing the 751-amino acid isoform of human beta-amyloid precursor protein" 92 : 5341-5345, 1995

28 Takeuchi A, "Age-related amyloid β deposition in transgenic mice overexpressing both alzheimer mutant presenilin 1 and amyloid β precursor protein swedish mutant is not associated with global neuronal loss" 157 : 331-339, 2000

29 Kawarabayashi T, "Age-dependent changes in brain, csf, and plasma amyloid β protein in the tg2576 transgenic mouse model of alzheimer's disease" 21 : 372-381, 2001

30 Pompl PN, "Adaptation of the circular platform spatial memory task for mice: Use in detecting cognitive impairment in the appsw transgenic mouse model for alzheimer's disease" 87 : 87-95, 1999